Prognostic Neuroimaging Biomarkers in Acute Vascular Brain Injury and Traumatic Brain Injury

Semin Neurol. 2023 Oct;43(5):699-711. doi: 10.1055/s-0043-1775790. Epub 2023 Oct 6.

Abstract

Prognostic imaging biomarkers after acute brain injury inform treatment decisions, track the progression of intracranial injury, and can be used in shared decision-making processes with families. Herein, key established biomarkers and prognostic scoring systems are surveyed in the literature, and their applications in clinical practice and clinical trials are discussed. Biomarkers in acute ischemic stroke include computed tomography (CT) hypodensity scoring, diffusion-weighted lesion volume, and core infarct size on perfusion imaging. Intracerebral hemorrhage biomarkers include hemorrhage volume, expansion, and location. Aneurysmal subarachnoid biomarkers include hemorrhage grading, presence of diffusion-restricting lesions, and acute hydrocephalus. Traumatic brain injury CT scoring systems, contusion expansion, and diffuse axonal injury grading are reviewed. Emerging biomarkers including white matter disease scoring, diffusion tensor imaging, and the automated calculation of scoring systems and volumetrics are discussed.

MeSH terms

  • Brain / pathology
  • Brain Injuries*
  • Brain Injuries, Traumatic* / diagnostic imaging
  • Brain Injuries, Traumatic* / pathology
  • Cerebrovascular Trauma* / pathology
  • Diffusion Tensor Imaging
  • Hemorrhage / pathology
  • Humans
  • Ischemic Stroke* / pathology
  • Magnetic Resonance Imaging / methods
  • Neuroimaging / methods
  • Prognosis